Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

Exclusion Criteria

• •Latex allergy.
• •Subject has any active infection (including chronic or localized infections) for which anti-infectives were indicated within 4 weeks prior to first study dose of etanercept.
• •Subject had prosthetic joint infection within 5 years of screening or native joint infection within 1 year of screening.
• •Other criteria may apply.